May 2023

Comprehensive in-hospital planning, postdischarge follow-up, ongoing support are key.

Pharmacists should continue to monitor payer policy changes and reimbursement rates and improve understanding of electronic order entry.

Understanding causes, consequences proves vital to develop therapies that exploit vulnerabilities of the cancer cells.

Delivery, manufacturing concerns hinder green light from US Agency, but European Medicines Agency approves treatment.

Improving awareness and getting involved in local or national initiatives can enable pharmacists to make change.

When considering outsourcing, pharmacies should use a multistakeholder team to weigh pros and cons.

Health systems must address drivers of attrition, turnover.

Health-system pharmacies should fight the well-orchestrated attempt to dismantle 340B drug pricing.

Key topics in May include mental illness for pharmacists, pharmacy technicians, and PharmD candidates.